共 111 条
[1]
Wiegman A(2015)Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Eur Heart J 36 2425-2437
[2]
Gidding SS(2014)Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society Eur Heart J 35 2146-2157
[3]
Watts GF(2015)Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials Curr Opin Lipidol 26 586-592
[4]
Cuchel M(2016)Management of homozygous familial hypercholesterolemia in real-world clinical practice: a report of 7 Italian patients treated in Rome with lomitapide and lipid apheresis J Clin Lipidol 10 782-789
[5]
Bruckert E(2017)Knowns and unknowns in the care of pediatric familial hypercholesterolemia J Lipid Res 58 1765-1776
[6]
Ginsberg HN(2015)Lipid apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances Curr Atheroscler Rep 17 465-133
[7]
Sijbrands EJ(2007)Three-year-old boy--a homozygote for familiar hypercholesterolemia Lijecnicki Vjesnik 129 130-50
[8]
Nieman K(2012)Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia JIMD Rep 2 45-139
[9]
Budoff MJ(2011)Sudden death in a 4-year-old boy: a near-complete occlusion of the coronary artery caused by an aggressive low-density lipoprotein receptor mutation (W556R) in homozygous familial hypercholesterolemia J Pediatr 158 167-526
[10]
Stefanutti C(2012)Homozygous familial hypercholesterolaemia Lancet 379 1330-27